Press Releases

All Releases
May 13, 2008
AngioDynamics Closes Acquisition of Oncobionic
AngioDynamics Closes Acquisition of Oncobionic Company Will Now Move to Provide 20 IRE Systems to Soft Tissue Ablation Thought Leaders QUEENSBURY, N.Y.--(BUSINESS WIRE)--May 13, 2008--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists,
Apr 02, 2008
AngioDynamics Reports Fiscal Third Quarter 2008 Financial Results and Announces Settlement of Patent Litigation With Diomed

-- Sales Increase 52% to $40.7 Million<br>

-- Net Income (including settlement with Diomed) of $4.9 Million and EPS of $0.20<br>

-- Adjusted Income (Non GAAP) of $7.2 Million and Adjusted EPS (Non GAAP) of $0.30 Per Share<br>

-- Record Cash Flow from Operations of $9.9 Million During Quarter<br>

-- Conference Call Begins Today at 4:30 p.m. Eastern Time

Jan 17, 2008
Court Denies Diomed Motion Against AngioDynamics
Court Denies Diomed Motion Against AngioDynamics QUEENSBURY, N.Y., Jan 17, 2008 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular
Jan 03, 2008
AngioDynamics Reports 70% Second Quarter Sales Growth

Operating Income Increases 59% -- Net Income Grows 26% to $3.1 Million or $0.13 Per Share -- (Non GAAP) Adjusted Income Increases 140% to $7.3 Million or $0.30 Per Share -- Guidance Reaffirmed for Fiscal Year 2008 -- Conference Call Begins Today at 4:30 p.m. Eastern Time

Dec 19, 2007
AngioDynamics Issues Radiofrequency Ablation Statement
AngioDynamics Issues Radiofrequency Ablation Statement QUEENSBURY, N.Y., Dec 19, 2007 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally invasive treatment of cancer and peripheral
Displaying 361 - 380 of 687